Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177606 · ClinicalTrials.gov registry record
Donors After Cardiac Death: Validating Identification Criteria
A clinical trial of Withdrawing Treatment, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 600
- Enrollment target
- 4
- Study locations
NCT00177606: Completed study of Withdrawing Treatment, sponsored by University of Pittsburgh.
NCT00177606 is a study of Withdrawing Treatment that has completed, run by University of Pittsburgh. The registered enrollment target is 600 participants. The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177606, a study of Withdrawing Treatment, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to validate a set of proposed clinical criteria that have been designed to identify patients who will die rapidly following the elective removal of life sustaining treatments.
Conditions Studied
Interventions
- BEHAVIORAL withdrawal of life sustaining treatments
Study Locations (4)
Ohio
- University of Cincinnati Medical Center - Cincinnati
- Case Western Reserve University - Cleveland
Pennsylvania
- Childrens Hospital of Pittsburgh - Pittsburgh
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2003-07 |
| Est. Completion | 2007-12 |
What the finished NCT00177606 record still lists
NCT00177606 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Withdrawing Treatment appearing as the primary indexed condition, and to 1 intervention - of which withdrawal of life sustaining treatments is the first listed.
NCT00177606 reports a single indexed study location in Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00177606 about?
NCT00177606 is a clinical study titled "Donors After Cardiac Death: Validating Identification Criteria". The purpose of this study is to validate a set of proposed clinical criteria that have been designed to identify patients who will die rapidly following the elective removal of life sustaining treatments.
What is the current status of trial NCT00177606?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2003-07. Estimated completion is 2007-12.
What conditions does trial NCT00177606 study?
This clinical trial studies the following conditions: Withdrawing Treatment.
What interventions are being tested in trial NCT00177606?
The interventions under investigation include: withdrawal of life sustaining treatments (BEHAVIORAL).
Who is sponsoring clinical trial NCT00177606?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00177606 being conducted?
This trial has 4 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia